【第1章】
1. Takatsuki K, Uchiyama T, Sagawa K, Yodoi J. Adult T-cell Leukemia in Japan. In:
Seno S, Takaku F, Irino S, eds. Topics in Hematology. Amsterdam: Excerpta Medica, 1977: 73-77.
2. Miyoshi I, Kubonishi I, Sumida M, et al. A novel T-cell line derived from adult T-cell leukemia. Gann 1980; 71: 155-156.
3. Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 6476-6480.
4. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the diseases. Proc Natl Acad Sci USA 1982; 79: 2031-2035.
5. Poiesz B, Ruscetti F, Gazdar A-F, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad.Sci USA 1980; 77: 7415-7419.
6. Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus:
Complete nucleotide sequence of the provirus genomes integrated in leukemia cell DNA. Proc Natl Acad Sci USA 1982; 80: 3618-3622.
7. Popovic M, Reitz MS, Sangadharan MG, et al. The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group. Nature 1982;
300: 63-66.
8. Kinoshita K, Hino, S, Amagasaki T, et al.: Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers. Jpn J Cancer Res 75:
103-105, 1984.
9. Nakano S, Ando Y, Ichiro M, et al.: Search for possible routes of vertical and horizontal transmission of adult T-cell leukemia virus. Jpn J Cancer Res 75:
1044-1045 1984.
10. Yoshida M, Fujisawa J. Positive and negative of HTLV-1 gene expression and their roles in leukemogenesis in ATL. Gann Monograph on Cancer Research 1992; 39:
217-235.
11. Jacobson S, Shida H, McFarlin DE, et al. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I-associated neurological diseases.
Nature 1990; 348: 245-248.
12. Satou Y, Yasunaga J, Zhao T, et al. HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo. PLoS Pathogens 2011;7(2):e1001274
13. Osame M, Usuku K, Izumo S, et al. HTLV-I-associated myelopathy: a new clinical entity. Lancet 1986; i: 1031-1032.
14. Usuku K, Sonoda S, Osame M, et al. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol 1988; 23(suppl): S143-150.
15. Kusuhara K, Sonoda S, Takahashi K, Tokugawa K, Fukushige J, Ueda K.
Mother-to-child transmission of human T-cell leukemia virus type I (HTLV-I): a fifteen-year follow-up study in Okinawa, Japan. Int J Cancer 1987; 40:755-757.
16. Matsumoto C, Mitsunaga S, Oguchi T, et al. Detection of human T-cell leukemia virus type I (HTLV-I) provirus in an infected cell line and in peripheral mononuclear cells of blood donors by the nested double polymerase chain reaction method:
comparison with HTLV-I antibody tests. J Virol 1990; 64: 5290-5294.
17. Hino S, Katamine S, Miyata H, et al. Primary prevention of HTLV-1 in Japan.
Leukemia 1997; 11: S57-59.
- 75 -
18. Takahashi T, Takezaki T, Oki T, et al. Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I. Int J Cancer 1991; 49: 673-677.
19. Ando Y, Nakano S, Saito K, et al. Prevention of HTLV-I transmission through the breast milk by a freeze-thawing process. Jpn J Cancer Res 1986; 77: 974-977.
【第2章】
1. 厚生労働省科学研究費補助金新型インフルエンザ等新興・再興感染症研究事業「本 邦におけるHTLV-1 感染及び関連疾患の実態調査と総合対策」研究班(主任研究者 山口一成). 平成21年度総括報告書.
2. Yashiki S, Fujiyoshi T, Arima N, et al. HLA-A*26, HLA- B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epi- topes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes. AIDS Res Hum Retroviruses 2001; 17:
1047-1061.
3. Usuku K, Sonoda S, Osame M, et al. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol Suppl 1988; 23: S143-S150.
4. T・Bリンパ系腫瘍研究グループ（広瀬加緒瑠、田島和雄）. 第6次成人T細胞白 血病/リンパ腫（ATL）全国実態調査の報告. 癌の臨床 1994; 40: 229-246.
5. Tajima K, Hinuma Y. Epidemiology of HTLV-I/II in Japan and in the world. Gann Mono. In: Hinuma Y, Takatsuki K, Yoshida M, eds. Advances in ATL and HTLV-I Research. Tokyo: Japan Scientific Society, 1992; 39.
6. Li HG, Fujiyoshi T, Lou H, et al. The presence of ancient human T-cell lymphotrophic virus type I provirus DNA in an Andean mummy Nat Med 1999; 5:
1428-1432.
7. 園田俊郎、藤吉利信、屋敷伸治、楼宏、レマ・カロリーナ. HLAとHTLV-I. ウイル ス 2000; 50: 37-45.
8. Tajima K, Ito S, Tsushima ATL Study Group. Prospective studies of HTLV-I and associated diseases in Japan. In: Blattner WA ed. Human Retrovirology HTLV.
New York: Raven Press, 1990: 267-279.
9. Tajima K, Tominaga S, Suchi T, et al. Epidemiological analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen: Possible horizontal transmission of adult T-cell leukemia virus. Jpn J Cancer Res 1982; 73: 893- 901.
10. Kusuhara K, Sonoda S, Takahashi K, et al. Mother-to-child transmission of human T-cell leukemia virus type I (HTLV-I): A fifteen-year follow-up study in Okinawa.
Japan. Int J Cancer 1987; 40: 755-757.
【第3章】
1. Shimoyama M, Members of Diagnostic Criteria and Classification of Clinical Subtypes of Adult T-cell Leukemia-Lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991; 79: 428-437.
2. 厚生労働省科学研究費補助金新型インフルエンザ等新興・再興感染症研究事業「本 邦における HTLV-1 感染及び関連疾患の実態把握と総合対策」研究班(主任研究者 山口一成). 平成20年度研究総括報告書.
3. T・Bリンパ系腫瘍研究グループ. 第9次成人T細胞白血病/リンパ腫（ATL）全国実
態調査の報告. 癌の臨床 2001; 47: 341-357.
4. Hishizawa M, Kanda J, Utsunomiya A, et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationawide retrospective study.
Blood 2010; 116: 1369-1376.
5. Ishida T, Joh T, Uike N, et al. Multicenter phase II study of KW-0761, a defucosylated anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma (ATL). Abstract #285. 52nd American Society for Hematology Annual Meeting. Orlando, USA. December 4-7, 2010.
- 76 -
6. Shimoyama M, members of The Lymphoma Study Group (1984-87). Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma: A report from The Lymphoma Study Group (1984-87). Br J Haematol 1991; 79:
428-437.
7. Yamada Y, Tomonaga M, Fukuda H, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 2001; 113: 375-382.
【第4章】
1. Fujino R, Kawato K, Ikeda M, et al. Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody. Jpn J Cancer Res (Gann) 1991; 82: 367-370.
2. Fujiyama C, Fujiyoshi T, Matsumoto D, Tamashiro H, Sonoda S. Evaluation of commercial HTLV-1 test kits by a standard HTLV-1 serum panel. Bull WHO 1995;
73: 515-521.
3. Taguchi H, Sawada T, Fujishita M, Morimoto T, Niiya K, Miyoshi I. Enzyme-linked immunosorbent assay of antibodies to adult T-cell leukemia-associated antigen. Jpn J Cancer Res (Gann) 1983; 74: 185-187.
4. Gallo D, Hoffman MN, Cossen CK, Diggs JL, Hurst JW, Penning LM. Comparison of immunofluorescence, enzyme immunoassay, and Western blot (immunoblot) methods for detection of antibody to humanT-cell leukemia virus type I. J Clin Microbiol 1988; 26: 1487-1491.
5. World Health Organisation. Acquired immunodeficiency syndrome (AIDS): proposed WHO criteria for interpreting results from western blot assays for HIV-1, HIV-2, and HTLV-I/HTLV-II. Week Epidemiol Rec, 1990.
6. Kamihira S, Dateki N, Sugahara K, et al. Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count.
Clin Lab Haem 2003; 25: 111-117.
7. Iwanaga M, Watanabe T, Utsunomiya A, et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood 2010; 116: 1211-1219.
8. 厚生労働省科学研究費補助金行政政策研究分野厚生労働科学特別研究「HTLV-1 母 子感染予防に関する研究」研究班(主任研究者 齋藤滋). 平成 21 年度研究総括報告 書.
【第5章】
1. 平成20年度宮崎県母子保健運営協議会 ATL母子感染防止対策専門部会資料 2. Hino S, Yamaguchi K, Katamine S, et al. Mother-to-child transmission of human
T-cell leukemia virus type-I. Jpn J Cancer Res (Gann) 1985; 76: 474-480
3. 長崎県ATLウイルス母子感染防止研究協力事業連絡協議会. 長崎県 ATLウイルス 母子感染防止研究協力事業（APP）報告書〜20年のあゆみ〜. 平成20年3月. 4. 鹿児島県ATL制圧委員会：鹿児島県ATL制圧10カ年計画報告書. 平成18年3月.
5. Kawase K, Katamine S, Moriuchi R, et al. Maternal transmission of HTLV-I other than through breast milk: Discrepancy between the polymerase chain reaction positivity of cord blood samples for HTLV-I and the subsequent seropositivity of individuals. Jpn J Cancer Res 1992; 83: 968-977.
6. Katamine S, Moriuchi R, Yamamoto T, et al. HTLV-I proviral DNA in umbilical cord blood of babies born to carrier mothers. Lancet 1994; 343: 1326-1327.
7. Yamamoto T, Terada K, Nishida N, et al. Inhibitory activity in saliva of cell-to-cell transmission of human T-cell lymphotropic virus type I in vitro: Evaluation of saliva as an alternative source of transmission. J Clin Microbiol 1995; 33:
1510-1515.
8. 一条元彦、高月清 編：ATLウイルスの母児感染対策. 東京：南江堂, 1989:
85-86.